Literature DB >> 22231970

Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service.

Anna Paula de Sá Borges1, Camilo Molino Guidoni, Osvaldo de Freitas, Leonardo Régis Leira Pereira.   

Abstract

OBJECTIVE: To analyze the costs related to visits and drug prescription in outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service. SUBJECTS AND METHODS: A prospective and experimental study was carried out. Seventy one patients were divided into two groups: control and pharmaceutical care. Patients in the pharmaceutical care group were followed up monthly by a single clinical pharmacist.
RESULTS: The pharmaceutical care group had a statistically significant reduction in costs of metformin and emergency department visits, and increased costs with their family physicians. On the other hand, the control group had a statistically significant increase of 21.3% in the general costs of treatment and visits.
CONCLUSION: The pharmaceutical care group maintained the same costs related to drugs and visits, while the control group showed a significant increase in general costs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22231970     DOI: 10.1590/s0004-27302011000900003

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  9 in total

Review 1.  Association between ADIPOQ +45T>G polymorphism and type 2 diabetes: a systematic review and meta-analysis.

Authors:  Yaofu Fan; Kun Wang; Shuhang Xu; Guofang Chen; Hongjie Di; Meng Cao; Chao Liu
Journal:  Int J Mol Sci       Date:  2014-12-30       Impact factor: 5.923

2.  Does pharmacist-supervised intervention through pharmaceutical care program influence direct healthcare cost burden of newly diagnosed diabetics in a tertiary care teaching hospital in Nepal: a non-clinical randomised controlled trial approach.

Authors:  Dinesh Kumar Upadhyay; Mohamed Izham Mohamed Ibrahim; Pranaya Mishra; Vijay M Alurkar; Mukhtar Ansari
Journal:  Daru       Date:  2016-02-29       Impact factor: 3.117

3.  Impact Assessment of Pharmaceutical Care in the Management of Hypertension and Coronary Risk Factors after Discharge.

Authors:  Maurílio de Souza Cazarim; Osvaldo de Freitas; Thais Rodrigues Penaforte; Angela Achcar; Leonardo Régis Leira Pereira
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

Review 4.  Changes of Regulatory T Cells and of Proinflammatory and Immunosuppressive Cytokines in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Authors:  Yong-Chao Qiao; Jian Shen; Lan He; Xue-Zhi Hong; Fang Tian; Yan-Hong Pan; Ling Liang; Xiao-Xi Zhang; Hai-Lu Zhao
Journal:  J Diabetes Res       Date:  2016-09-29       Impact factor: 4.011

5.  Hospital pharmacy workforce in Brazil.

Authors:  Thiago R Santos; Jonathan Penm; André O Baldoni; Lorena Rocha Ayres; Rebekah Moles; Cristina Sanches
Journal:  Hum Resour Health       Date:  2018-01-04

Review 6.  The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: A systematic review and meta-analysis.

Authors:  Yong-Chao Qiao; Yin-Ling Chen; Yan-Hong Pan; Fang Tian; Yan Xu; Xiao-Xi Zhang; Hai-Lu Zhao
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

7.  Cost-effectiveness analysis of pharmaceutical care for hypertensive patients from the perspective of the public health system in Brazil.

Authors:  Maurílio de Souza Cazarim; Leonardo Régis Leira Pereira
Journal:  PLoS One       Date:  2018-03-06       Impact factor: 3.240

8.  The costs of diabetes treatment in low- and middle-income countries: a systematic review.

Authors:  Corrina Moucheraud; Cosima Lenz; Michaella Latkovic; Veronika J Wirtz
Journal:  BMJ Glob Health       Date:  2019-02-27

9.  Cost-effectiveness analysis of a pharmacotherapeutic empowerment strategy for patients with type 2 diabetes mellitus.

Authors:  Ana Carolina Oliveira Gonçalves; Maurílio de Souza Cazarim; Cristina Sanches; Leonardo Regis Leira Pereira; Ana Márcia Tomé Camargos; Jéssica Azevedo Aquino; Andre Oliveira Baldoni
Journal:  BMJ Open Diabetes Res Care       Date:  2019-07-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.